Hib conjugate vaccine (Changchun Baike)

b型流感嗜血杆菌结合疫苗（长春百克）

Report date: 2024/12/25 14:57:46

Base Information

Drug NameHib conjugate vaccine (Changchun Baike)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHaemophilus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesChangchun Bcht Biotechnology Co

China Registration ClassN/A

Develop Information

Active CompaniesChangchun Bcht Biotechnology Co

Inactive CompaniesN/A

Active IndicationsHaemophilus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A